CCO Podcast: Managing Change Amid Controversy at Novavax
Update: 2025-09-21
Description
Novavax CCO Silvia Taylor discusses the company’s role in developing a Covid vaccine, the ensuing vaccine controversy, and how Novavax refined its strategy and its positioning. Throughout those challenges, the corporate affairs function has managed multiple stakeholder relationships, with an emphasis on adding commercial value.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
